| |
| |
|
| Insider
Information: |
Moore Timothy L. |
| Relationship: |
|
| City: |
Santa Monica |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
400,429 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$703,769 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
400,429 |
|
|
| Total
Value |
$703,769 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 34.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kite Pharma, Inc. |
KITE |
EVP, Technical Operati... |
2017-10-03 |
0 |
2016-03-15 |
0 |
Premium* |
|
|
Cerus Corp |
CERS |
Director |
2023-06-07 |
105,073 |
2019-09-05 |
0 |
Premium* |
|
|
Biolife Solutions Inc |
BLFS |
Director |
2024-03-08 |
29,897 |
2022-09-01 |
0 |
Premium* |
|
|
Allogene Therapeutics, Inc. |
ALLO |
|
2024-04-22 |
265,459 |
2023-04-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• • – |
2024-04-22 |
4 |
D |
$3.47 |
$60,189 |
D/D |
(17,360) |
265,459 |
0 |
- |
|
| BLFS |
Biolife Solutions Inc |
Director |
– • – |
2024-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
11,264 |
29,897 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• • – |
2024-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
96,600 |
282,819 |
0 |
- |
|
| BLFS |
Biolife Solutions Inc |
Director |
– • – |
2023-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
362 |
18,138 |
0 |
- |
|
| CERS |
Cerus Corp |
Director |
– • – |
2023-06-07 |
4 |
A |
$5.00 |
$200,000 |
D/D |
40,000 |
105,073 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• • – |
2023-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
186,219 |
186,219 |
0 |
- |
|
| BLFS |
Biolife Solutions Inc |
Director |
• • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
10,187 |
17,776 |
0 |
- |
|
| BLFS |
Biolife Solutions Inc |
Director |
• • – |
2022-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,589 |
7,589 |
0 |
- |
|
| CERS |
Cerus Corp |
Director |
– • – |
2022-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,454 |
65,073 |
0 |
- |
|
| CERS |
Cerus Corp |
Director |
– • – |
2021-09-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,296 |
44,619 |
0 |
- |
|
| CERS |
Cerus Corp |
Director |
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
14,888 |
40,323 |
0 |
- |
|
| CERS |
Cerus Corp |
Director |
– • – |
2021-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,228 |
25,435 |
0 |
- |
|
| CERS |
Cerus Corp |
Director |
– • – |
2020-09-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,296 |
12,207 |
0 |
- |
|
| CERS |
Cerus Corp |
Director |
– • – |
2020-02-11 |
4 |
B |
$4.75 |
$17,165 |
D/D |
3,614 |
7,911 |
2.39 |
% |
|
| CERS |
Cerus Corp |
Director |
– • – |
2020-01-29 |
4/A |
B |
$0.00 |
$0 |
D/D |
0 |
4,297 |
2.31 |
- |
|
| CERS |
Cerus Corp |
Director |
– • – |
2020-01-29 |
4 |
B |
$4.15 |
$14,998 |
D/D |
3,614 |
7,911 |
2.39 |
% |
|
| CERS |
Cerus Corp |
Director |
– • – |
2019-09-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,297 |
4,297 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Technical Operations |
• – – |
2017-10-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(41,734) |
0 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Technical Operations |
• – – |
2017-10-03 |
4 |
D |
$180.00 |
$706,860 |
D/D |
(3,927) |
41,734 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Technical Operations |
• – – |
2017-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
49,889 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Technical Operations |
• – – |
2017-09-25 |
4 |
S |
$179.66 |
$759,619 |
D/D |
(4,228) |
45,661 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Technical Operations |
• – – |
2017-08-03 |
4 |
AS |
$110.05 |
$660,343 |
D/D |
(6,000) |
49,400 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Technical Operations |
• – – |
2017-08-03 |
4 |
OE |
$44.91 |
$269,460 |
D/D |
6,000 |
55,400 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Technical Operations |
• – – |
2017-08-01 |
4 |
OE |
$44.91 |
$134,730 |
D/D |
3,000 |
61,400 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Technical Operations |
• – – |
2017-08-01 |
4 |
AS |
$106.85 |
$1,292,322 |
D/D |
(12,000) |
49,400 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
